OFIX Orthofix Medical Inc
Price (delayed)
$17
Market cap
$648.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.19
Enterprise value
$757M
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with
Highlights
The gross profit has increased by 29% year-on-year and by 3% since the previous quarter
The revenue is up by 29% year-on-year
Orthofix Medical's debt has soared by 94% YoY
The equity has contracted by 15% YoY and by 4.3% from the previous quarter
Key stats
What are the main financial stats of OFIX
Market
Valuations
Earnings
Shares outstanding
38.17M
Market cap
$648.97M
Enterprise value
$757M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.17
Price to sales (P/S)
0.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
Revenue
$771.65M
EBIT
-$102.39M
EBITDA
-$46.43M
Free cash flow
-$73.76M
Per share
Balance sheet
Liquidity
EPS
-$3.19
Free cash flow per share
-$1.94
Book value per share
$14.55
Revenue per share
$20.3
TBVPS
$15.22
Total assets
$882M
Total liabilities
$335.99M
Debt
$136.9M
Equity
$546M
Working capital
$230.1M
Debt to equity
0.25
Current ratio
2.48
Quick ratio
0.99
Net debt/EBITDA
-2.33
Margins
Efficiency
Dividend
EBITDA margin
-6%
Gross margin
67.2%
Net margin
-15.6%
Operating margin
-12.6%
Return on assets
-13.3%
Return on equity
-20.7%
Return on invested capital
-19.5%
Return on capital employed
-14.1%
Return on sales
-13.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OFIX stock price
How has the Orthofix Medical stock price performed over time
Intraday
-2.3%
1 week
-0.18%
1 month
5.99%
1 year
30.67%
YTD
26.11%
QTD
28.21%
Financial performance
How have Orthofix Medical's revenue and profit performed over time
Revenue
$771.65M
Gross profit
$518.38M
Operating income
-$97.01M
Net income
-$120.49M
Gross margin
67.2%
Net margin
-15.6%
The company's operating margin rose by 33% YoY and by 12% QoQ
The gross profit has increased by 29% year-on-year and by 3% since the previous quarter
The revenue is up by 29% year-on-year
Orthofix Medical's net margin has increased by 21% YoY and by 6% from the previous quarter
Growth
What is Orthofix Medical's growth rate over time
Valuation
What is Orthofix Medical stock price valuation
P/E
N/A
P/B
1.17
P/S
0.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.98
The EPS has grown by 13% YoY and by 6% from the previous quarter
The stock's price to book (P/B) is 33% more than its last 4 quarters average of 0.9 but 25% less than its 5-year quarterly average of 1.6
The equity has contracted by 15% YoY and by 4.3% from the previous quarter
The price to sales (P/S) is 34% lower than the 5-year quarterly average of 1.3 but 23% higher than the last 4 quarters average of 0.7
The revenue is up by 29% year-on-year
Efficiency
How efficient is Orthofix Medical business performance
The ROIC has grown by 39% YoY and by 11% from the previous quarter
The ROS has grown by 28% YoY and by 10% from the previous quarter
OFIX's return on assets is up by 23% year-on-year and by 4.3% since the previous quarter
OFIX's ROE is up by 13% YoY
Dividends
What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OFIX.
Financial health
How did Orthofix Medical financials performed over time
The total assets is 163% greater than the total liabilities
The company's total liabilities rose by 29% YoY
The current ratio has contracted by 12% YoY and by 6% from the previous quarter
Orthofix Medical's debt is 75% less than its equity
OFIX's debt to equity has soared by 127% YoY and by 4.2% from the previous quarter
Orthofix Medical's debt has soared by 94% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.